5 High-Growth Businesses to Build as India Fast-Tracks High-End Medical Device Manufacturing

Medical Device Manufacturing Business in India

An ₹89,000 Crore Import Problem Becomes India’s Biggest Startup Signal

India has become a medical device importer nation with its bill exceeding ₹89,000 crore, and the government is finally declaring it a national manufacturing emergency. The government is making significant push to locally manufacture 10 “highly advanced” high-precision medical devices like the most commonly prescribed “holy grail devices” like pacemakers, MRI scan machines, next-generation ultrasound devices and Continuous Glucose Monitoring (CGM), the Economic Times Manufacturing reported on June 25, 2026. This isn’t just a healthcare policy update for founders, MSMEs or industrial investors. It’s a green light for an entire eco-system of new businesses.

India imports almost 70% of its medical device’s requirements. Some of the more sophisticated equipment (high-end imaging systems, surgical robots, specialized monitors in intensive care units etc.) does not yet have an equivalent at the level or dimensions required in the domestic market. For the first time, the government has officially acknowledged that local production of these ten high-value devices is a viable policy and offers financial incentives and is in a state of industrial readiness.

This article dissects the implications of this Economic Times report for entrepreneurs, the current business opportunities it presents, and why now is a better opportunity than ever for business.

Access Complete Business Plan: Medical Devices & Disposables Industry in India 

What Recent Economic Times Reporting Means

But the time has now come to put those into action – and it would seem that India has been determined to bring that promise into reality with the help of a bold move for the high-end medical device sector – according to an Economic Times Manufacturing report dating June 25 2026. The time has indeed come for policy to follow suit – as indicated with an article in Economic Times Manufacturing on June 25 2026 of the decision by the Indian government for increased production of high-end medical devices. The government is no longer merely talking about lessening its reliance on imports; it is calling out certain devices and certain barriers and asking industry to put forth specific solutions. To read the complete report, click here: ET Manufacturing — Govt Eyes Fast-Tracking Local Production of High-End Medical Devices

The ten devices under scrutiny are not ‘commodity’ devices. These are among the different categories of electronics, which make up the bulk of the import bill for medical devices in India, including MRI systems, pacemakers, CGM devices, high end ultrasound systems, advanced in-vitro diagnostic (IVD) analysers, X-ray tubes, imaging detectors and ultrasound probes.(Medical Device Manufacturing Business in India)

Three Market Signals Every Founder Must Understand

• Signal 1: The incentive window is opening wider, as the government is looking into targeted support for R&D, a review of tariffs on imported components, and a possible PLI 2.0 for complex MedTech.
• Signal 2: The India-US interim trade deal has lowered import duties on medical devices from US 50% to 18%, enhancing the export potential of any medical device manufacturer who is able to meet the global standards.
• Signal 3: At the same time, the Department of Pharmaceuticals has launched a new consultation period on the GTE (Global Trade Enquiry) exemption list, which will determine the type of devices that will get preferential treatment in the public procurement process.

These three signals combine to form an unusual combination: the government is withdrawing the incentives for imported devices that can be manufactured locally and at the same time increasing support for domestic manufacturers to replace this. For founders in early stages, this window will not remain open for long.

Why This Industry Is Growing: The Numbers Tell the Story

India’s medical devices market will expand 3x from $15.2 bn in 2025 to $50.1 bn by 2030. Economic Times has been monitoring the trend of this sector to be among the most investable among the industrial giants in India since its inception. According to Confederation of Indian Industry (CII), MedTech exports may grow to as high as ₹1,69,000 crore till FY30.

The current PLI scheme for medical devices, which has been launched with an outlay of ₹3,420 crore, has already proven to be effective. As part of the scheme, 22 greenfield manufacturing projects have been commissioned, over 55 medical devices have been inaugurated at home (including MRI, CT, mammography systems and ultrasound machines) and sales have touched ₹12,344 crore, with exports nearing ₹5,870 crore.

However, these are just a few of the things that these incentives in Phase 1 could do. The devices that India is seeking to make – as per a recent report in the Economic Times – demand a very different manufacturing environment: precision mechatronics, imaging physics skills, bioelectronics solutions, and ISO 13485 compliance and quality management on a scale that has yet to be achieved.

This is the opportunity. With the government’s push, there is a need for not only device makers but also for an entire ecosystem of providers, which include component suppliers, testing labs, regulatory consultants, skilled workforce trainers, and industrial park developers.(Medical Device Manufacturing Business in India)

Get Detailed Insights from This Book: Handbook on Medical and Surgical Disposable Products

Government Policies & Incentives: What Founders Need to Know

PLI Scheme for Medical Devices

The Production Linked Incentive Scheme (PLI) is providing a 5% incentive for the four high importing product segments for the next four years, from 2022-23 to 2026-27, namely cancer care and radiotherapy equipment, radiology and imaging equipment, nuclear imaging equipment and implants. There is an active PLI 2.0 for complex MedTech in progress. Keep updated on scheme changes on Register & Track at Department of Pharmaceuticals and Make in India

Medical Device Parks

There are now four notified medical device parks in India, including a big park at Yamuna Expressway Industrial Development Authority (YEIDA) with approved cost of ₹439 crore. Shared infrastructure, lower land prices and co-location with global players are available to Startups. More on the concept of industrial cluster support at MSME Ministry

Startup India MedTech Support

More than 360 MedTech innovators have been supported by MedTech Mitra, a government-led platform that brings the umbrella of coordination across ICMR, AIM, CDSCO and Kalam Institute of Health Technology. The Startup India Seed Fund Scheme provides up to ₹50 lakh for PoC, prototyping and market entry. Start at Explore at Startup India. Visit Startup India.

Export Incentives

The India-EU FTA has opened up a $572 billion pharma and MedTech market for India with liberalised tariffs. Indian manufacturers with ISO 13485 and CE mark are now getting a clear path for exports. To get export advice, go to DGFT

5 High-Growth Business Ideas Emerging from This ET-Reported Market Shift

Business Idea 1: Medical Device Component Manufacturing (Indigenization Specialist)

The government’s main problem is not assembly of the devices; it is the critical components. The MRI machine’s gradient coils, ultrasound transducer probes, imaging detectors and X-ray tube assemblies are almost all sourced from just a few international manufacturers. Any startup which selects any of the above categories of components and assembles them at its own premises with quality compliance will instantly become a strategic partner in the supply chain for any Indian OEM. Initial investment: Rs 2-5 crore in a precision manufacturing unit. Revenue generation: B2B supply to OEMs of devices as well as to government funded medical device parks.(Medical Device Manufacturing Business in India)

Business Idea 2: MedTech Regulatory Compliance Consulting

With increasingly stringent manufacturing standards and defined export routes in India, all MedTech manufacturers, irrespective of their scale, must get expert advice for CDSCO registration, ISO 13485 certification, CE marking and FDA 510(k) routes. Economic Times has reported that one of the major challenges in front of the Indian manufacturers in export is regulatory execution. A specialized regulatory affairs consultancy can have a very recurring business model, with retainers paid to MedTech startups and MSMEs for their work in this area. Initial investment: ₹30–50 lakh. Revenue Model: monthly retainers, project-based compliance management and export licensing support.

Business Idea 3: Medical Device Testing and Calibration Laboratory

India has very few testing laboratories for advanced medical devices, especially imaging devices, pacemaker parts and IVD analyzers, which are certified by NABL. Each export device must be certified to international standards prior to submission to CE or FDA. As the addition of more manufacturers into PLI 2.0, the demand will have been guaranteed by a certified testing lab located in a medical cluster area (Hyderabad, Pune, Ahmedabad or Noida). Initial investment: ₹1–3 crore. Business model: per test fee, long-term laboratory services agreements from manufacturers.

Choose the right startup backed by real market demand

Business Idea 4: MedTech Skilled Workforce Training Academy

The government’s own policy analysis shows that there is an inadequate workforce of individuals who are skilled in advanced clinical imaging, precision manufacturing, bioelectronics, and ISO 13485 compliant quality systems in India. Therefore, A specialised training institute will directly address this structural gap by offering NSDC-aligned courses in medical device manufacturing, calibration, quality assurance, and regulatory compliance. Moreover, This is not your typical coaching centre. It is a B2B, placement-linked academy that prepares talent for device manufacturers, hospital procurement teams, medical device park tenants, and other healthcare industry employers. The initial investment is in the range of ₹50 lakh to ₹1.5 crore. Revenue sources: course fees, training contracts funded by employers, and government skill development funding.

Business Idea 5: Continuous Glucose Monitoring (CGM) Device Manufacturing

The government has identified CGM devices as one of its top ten targets and India has a huge demand for such devices, as its diabetes burden is over 100 million patients. Compared to MRI machines or pacemakers, CGM devices are much less expensive to produce. Furthermore, Indian hardware startups can now fabricate these devices using precise biosensors, integrate wireless communication modules, and connect them with mobile applications, as these skills are becoming increasingly attainable. As a result, The domestic CGM manufacturer is able to reach the profitability range of 3–4 years in the government procurement market and retail consumer market. Additionally, Initial investment: ₹3–8 crore. Revenue structure: Device + consumables subscription – sensor changes every 10-14 days is high recurring revenue.

Import–Export Opportunity Analysis

The medical device import bill of India is ₹89,000 crore which is a structurally strong import-substitution case. However, this opportunity is not limited to the inside. The Economic Times report comes on the heels of a bigger export story: India’s medical technology export industry is aiming for ₹1,69,000 crore by FY30 and new trade pacts have paved the way.

Reached in January 2026, the India-EU Free Trade Agreement (FTA) has unlocked a $572 billion EU pharma and MedTech market. Additionally, The interim trade deal between the Indian and the US has lowered the import tariff on medical devices from 50% to 18%. Furthermore, India is also looking to increase its MedTech exports to the UK by threefold by 2030. Therefore, These are not projections but signed trade commitments that offer Indian manufacturers a genuine advantage, provided they invest in meeting today’s global quality standards.(Medical Device Manufacturing Business in India)

For MSMEs thinking about export opportunities: Focus on mid-complexity devices that Indian manufacturers already produce successfully, such as diagnostic equipment, hospital furniture, surgical instruments, disposable consumables, and point-of-care diagnostics. Meanwhile, The high value device categories mentioned in the ET report are a 7–10-year export construction game for start-ups with higher aspirations which the Government is now willing to co-fund, with subsidy and tariff protection.

Indian MSME & Startup Success Stories

Panacea Medical Technologies — Radiation Therapy Systems

Panacea Medical Technologies is Bangalore-based company that has become one of the most successful beneficiaries of PLIs in the medical device sector in India. The company is now producing linear accelerators for cancer radiotherapy, a technology which was 100% imported from Elekta (Sweden) and Varian Medical Systems (US). The success of Panacea has proved that in 10 years, startups can break the deep technology barrier in India with PLI.

Allengers Medical Systems — Imaging Equipment

Allengers Medical Systems, based in Chandigarh, has established its domestic manufacturing base in X-ray machines and imaging equipment in the domestic public health market as well as for export customers. The company has now become a textbook example for Indian MSME manufacturers to shift from an assembly to genuine manufacturing process with appropriate policy push.

Logy.AI — AI-Driven Medical Imaging

Supported by MedTech Mitra, and the associated incubation centres of AIM.AI is a new breed of Indian MedTech startups capable of developing hardware and software at the same time. Their AI-powered imaging analysis solution is expected to reduce radiologists’ workload while improving diagnostic accuracy, highlighting its potential in both domestic and export markets.

Related Article: Start a Medical Products Manufacturing Business in India: IV Fluids, Dialysis, Implants & More

How NPCS Can Help You Enter This Market

A medical device feasibility study is an initial and important step for entrepreneurs considering entering the medical device manufacturing arena to prove their concept. NPCS (Niir Project Consultancy Services) provides in-depth project reports, market feasibility studies and investment analysis for medical device manufacturing companies, ranging from regulatory pathways to plant setup expenses, raw material sourcing to financial projections etc.

Whether you’re reviewing a medical device component manufacturer’s project report, a testing lab, or a medical device start-up, a professionally-created project report gives you the credibility and information your business plan requires to approach banks, investors, and government programs.(Medical Device Manufacturing Business in India)

Key Market Data: India Medical Devices Sector at a Glance

Frequently Asked Questions (FAQs) for Founders & MSMEs

Q1. Which specific medical devices is the government targeting for fast-track manufacturing?

Here are the 10 high value items the government has its sight on: MRI devices, pacemakers, continuous glucose monitoring (CGM) devices, advance medical ultrasound, high-end IVD analysers, X-ray tubes, X-ray imaging detector, ultrasound probes, CT scanner parts, high-value mammography system

Q2. What is the PLI scheme for medical devices and is it still open for applications?

The present PLI scheme for medical devices provides an incentive of 5% on incremental sales for the financial year 2022-23 to the financial year 2026-27. The scheme is in its final year, but a PLI 2.0 specifically for high-end MedTech is under active consideration. Entrepreneurs should register on the Department of Pharmaceuticals portal to track announcements and apply early when PLI 2.0 opens.

Q3. How much investment is required to start a medical device manufacturing business in India?

Investment requirements vary widely by device category. A regulatory compliance consultancy can start at ₹30–50 lakh. It requires 1-3 crore to set up a medical device testing lab. A CGM device manufacturing plant costs anywhere between 3 and 8 crores. And a facility to build critical components for imaging machines might be somewhere between 5 and 15 crore (or more depending on the specific device components, type and scale).

Q4. What licenses and regulatory approvals are needed for medical device manufacturing in India?

All medical device manufacturers in India need CDSCO registration along with an ISO 13485 quality management system certification and a BIS certification for devices subject to mandatory standards. Companies seeking to sell their products abroad will need CE marking for EU or FDA registration for the USA and relevant certifications for their respective markets. The government has launched the MedTech Mitra portal to provide all the support required for obtaining these approvals.

Q5. Which Indian states offer the best incentives for medical device startups?

The current landscape, in India, provides the right mix of infrastructure, clusters, and state support in these regions; Andhra Pradesh (Vizag AMTZ cluster), Uttar Pradesh (YEIDA MedTech Park near Noida), Maharashtra (industrial clusters around Pune) and Karnataka (Bangalore). Entrepreneurs should explore state-level MSME subsidy schemes at MSME Ministry and DPIIT at DPIIT

Q6. Can Indian medical device MSMEs export to the US and EU?

Yes — and now with materially better economics. The India-US interim trade deal has reduced US import tariffs on Indian medical devices from 50% to 18%. The India-EU FTA has opened preferential access to a $572 billion EU pharma and MedTech market. Indian manufacturers need ISO 13485 certification, and CE marking for EU or FDA 510(k)/PMA approval for the US. Early investment in these certifications now directly supports long-term export revenue.

Conclusion: The Window Is Open — Act Before It Gets Crowded

That Economic Times’ June 25, 2026 coverage of the push to ramp up high-end medical devices manufacture isn’t solely about healthcare; it’s really not only just about Healthcare news either – it goes to the centre of the country’s industrial output. It is a market signal that confirms the direction of policy capital, import substitution pressure, and export opportunity for the next decade. India is spending ₹89,000 crore every year importing devices that it could manufacture domestically — and the government has now formally committed to changing that equation.

For founders and MSMEs reading this, the timing is genuinely critical. PLI 2.0 has not launched yet. The GTE exemption list has not been finalized. The new tariff structures are still bedding in. Manufacturers who enter the ecosystem now by building regulatory expertise, component capabilities, testing infrastructure, or workforce training capacity will establish themselves as industry leaders before the next wave of government procurement preferences takes effect.(Medical Device Manufacturing Business in India)

The five business ideas presented in this article are not theoretical. The Economic Times reported that policymakers designed the policy push to address these structural gaps, from which they derive directly. Each one has a realistic path to profitability, multiple revenue models, and the tailwind of the largest industrial policy shift India’s MedTech sector has seen in a generation.

The question is not whether this market will grow. The data and the government policy are unambiguous. The question is whether you will be a founder who acts on this signal in 2026 — or a founder who reads about someone else’s success in 2030.